Oliver Eng MD,FACS

picture of Oliver  Eng

Associate Professor, Surgery
School of Medicine

Associate Director, Peritoneal Surface Malignancy Program, Surgery

Associate Director, Complex General Surgical Oncology Fellowship

Co-Director, Surgery Clerkship


M.D.

Phone: (714) 456-6015
Fax: (714) 456-6027
Email: oeng@uci.edu

University of California, Irvine
Department of Surgery
3800 Chapman Avenue, Suite 6200
Orange, CA 92868
Research Interests
Peritoneal surface malignancies, genomic heterogeneity, immune microenvironment, novel therapeutics, disparities in cancer care and access to care
Appointments
2022 - present Associate Professor of Surgery, University of California, Irvine
2018 - 2022 Assistant Professor of Surgery, University of Chicago
2021 - 2022 Assistant Professor, Gynecologic Oncology, University of Chicago (secondary appointment)
Awards and Honors
2011 The Prem Award—Outstanding Intern of the Year, Rutgers-RWJMS Department of Surgery
2013 The Susan B. Deak Award for Excellence in Research, Rutgers-RWJMS Department of Surgery
2015 Alpha Omega Alpha Honor Medical Society, Rutgers-RWJMS
2015 The Susan B. Deak Award for Excellence in Research, Rutgers-RWJMS Department of Surgery
2016 Graduate Medical Education & Clinical Training Resident/Fellow Travel Award, City of Hope National Medical Center
2017 Graduate Medical Education & Clinical Training Resident/Fellow Travel Award, City of Hope National Medical Center
2019 Selected Participant, ASCO/AACR Workshop on Methods in Clinical Cancer Research, Vail, Colorado
2019 Chinese Society of Clinical Oncology Annual Meeting/Society of Surgical Oncology International Travel Grant
2019 Faculty Excellence in Teaching Award, University of Chicago Department of Surgery
2020 Faculty Excellence in Teaching Award, University of Chicago Department of Surgery
2021 Junior Faculty Award, University of Chicago Comprehensive Cancer Center
2021 40 Under 40 in Cancer Award (The Lynx Group)
2021 Faculty Excellence in Teaching Award, University of Chicago Department of Surgery
Short Biography
Dr. Oliver Eng is a board-certified UCI Health surgical oncologist who specializes in the treatment of peritoneal surface malignancies, metastatic malignancies, advanced gastrointestinal cancers, sarcomas, and neuroendocrine tumors. He is an expert on the treatment of cancers in the abdomen, particularly cancers that have spread to the peritoneum, the membrane that lines the abdominal cavity. He specializes in complex cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC). HIPEC entails delivering high-dose heated chemotherapy in the operating room after surgical removal of visible disease and is effective in different types of cancers. Prior to joining UCI, Dr. Eng was on faculty at the University of Chicago, where he helped lead one of the most robust peritoneal surface malignancy programs in the country.

Dr. Eng has co-authored numerous peer-reviewed manuscripts in journals including Cancer Discovery, Cancer, British Journal of Cancer, and JAMA Surgery. He has received both extramural and intramural funding for his research, which centers on better understanding the molecular and immunologic characteristics of peritoneal tumors. His research aims to develop innovative therapies for metastatic disease and optimize outcomes and care in cancer patients. He has presented his work nationally and internationally, and he has served as a principal investigator or co-investigator on multiple clinical trials. Dr. Eng serves on the editorial board for a variety of scientific journals and has been appointed to a number of national committees. He has received numerous teaching and research awards, and was most recently a recipient of The Lynx Group’s 40 Under 40 in Cancer Award, which recognizes the contributions being made across the field of cancer by emerging leaders nationally.
Publications
1. Petrites AE, Eng OS, Mowlds DM, Simmons JA, DeLong CM. Interpulse interval modulation in echolocating big brown bats (Eptesicus fuscus) flying through obstacle clutter. Journal of Comparative Physiology A. June 2009;195(6):603-617. Epub 2009 Mar 26.
2. Davidov T, Trooskin SZ, Shanker BA, Yip D, Eng O, Crystal J, Deen MF, May M, Artymyshyn R. Routine second opinion cytopathology review of thyroid fine needle aspiration biopsies reduces diagnostic thyroidectomy. Surgery. December 2010;148(6):1294-1301.
3. Chernyavsky V, Shanker BA, Davidov T, Crystal J, Eng O, Ibrahim K, Kwong J, Trooskin SZ. Is one benign thyroid fine needle aspiration enough? Annals of Surgical Oncology. May 2012;19(5):1472-6. Epub 2011 Oct 4.
4. Eng OS, Goswami J, Moore D, Chen C, Brumbaugh J, Gannon CJ, August DA, Carpizo DR. Safety and efficacy of LigaSure usage in pancreaticoduodenectomy. HPB (Oxford). October 2013;15(10):747-52. Epub 2013 Jun 19.
5. Eng OS, Goswami J, Moore D, Chen C, Gannon CJ, August DA, Carpizo DR. Intraoperative fluid administration is associated with perioperative outcomes in pancreaticoduodenectomy: a single center retrospective analysis. Journal of Surgical Oncology. September 2013;108(4):242-7. Epub 2013 Aug 1.
6. Eng OS, Borah GL, Gannon CJ. Successful treatment of a rare massive Dabska tumor. ePlasty. September 10, 2013;13:382-7. eCollection 2013.
7. Shanker BA, Eng OS, Gendel V, Nosher J, Carpizo DR. Repair of a post-hepatectomy posterior sectoral duct injury secondary to anomalous bile duct anatomy using a novel combined surgical—interventional radiologic approach. Case Reports in Surgery. Vol. 2013, Article ID 202315, 6 pages, 2013.
8. Bernescu I, Eng OS, Potdevin L, Monteiro R, Mino J, Chang EI, Davidov T. Is a HIDA scan necessary for sonographically suspicious cholecystitis? Journal of Current Surgery. October 2013;3(2):62-65.
9. Eng OS, Lesniak S, Davidov T, Trooskin SZ. Diagnosing thyroid lymphoma: Steroid administration may result in rapid improvement of dyspnea: a report of two cases. International Journal of Endocrinology and Metabolism. January 2014;12(1):E11463. Epub 2014 Jan 1.
10. Macias CA, Arumugam D, Sanders R, Eng OS, Lu SE, Javidian P, Davidov T, Trooskin SZ. A risk model to determine surgical treatment in patients with thyroid nodules with indeterminate cytology. Annals of Surgical Oncology. May 2015;22(5):1527-32. Epub 2014 Nov 12.
11. Eng OS, Potdevin L, Davidov T, Lu S, Trooskin SZ. Does nodule size predict compressive symptoms in patients with thyroid nodules? Gland Surgery. November 2014;3(4):232-236.
12. Eng OS, Tsang AT, Narayanan S, Moore D, Chen C, Carpizo DR, Gannon CJ, August DA, Melstrom LG. Outcomes of microwave ablation for colorectal cancer liver metastases: a single center experience. Journal of Surgical Oncology. April 2015;111(4):410-3. Epub 2014 Dec 29.
13. Eng OS, Melstrom LG, Carpizo DR. The relationship of intraoperative fluid administration on perioperative outcomes in gastrointestinal surgery: a review of the literature. Journal of Surgical Oncology. April 2015;111(4):472-7. Epub 2015 Feb 2.
14. Lin H, Yu X, Eng OS, Buckley B, Kong A, Bertino J, Carpizo D, Gounder M. A sensitive liquid chromatography-mass spectrometry bioanalytical assay for the novel anticancer candidate—ZMC1. Biomedical Chromatography. 2015 Nov;29(11):1708-14. Epub 2015 May 5.
15. Eng OS, Arlow RL, Moore D, Chen C, Langenfeld JE, August DA, Carpizo DR. Fluid administration and morbidity in transhiatal esophagectomy. Journal of Surgical Research. 2016 Jan;200(1):91-7. Epub 2015 July 15.
16. Eng OS, Grant SB, Weissler J, Simon M, Roychowdhury S, Davidov T, Trooskin SZ. Operative bed recurrence of thyroid cancer: utility of a preoperative needle localization technique. Gland Surgery. 2016 Dec;5(6):571-575.
17. Eng OS, Dumitra S, O’Leary M, Wakabayashi M, Dellinger TH, Han ES, Lee SJ, Paz IB, Singh G, Lee B. Base excess as a predictor of complications in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Annals of Surgical Oncology. 2017 Sep;24(9):2707-2711. Epub 2017 May 30.
18. Eng OS, Dumitra S, O’Leary M, Raoof M, Wakabayashi M, Dellinger TH, Han ES, Lee SJ, Paz IB, Lee B. Fluid administration and morbidity in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. JAMA Surgery. 2017 Dec 1;152(12):1156-1160. Epub 2017 Aug 23.
19. Konstantinidis IT, Jutric J, Eng OS, Warner SG, Melstrom LG, Fong Y, Lee B, Singh G. Robotic Total Pancreatectomy with Splenectomy. Technique and Outcomes. Surgical Endoscopy. 2018 Aug;32(8):3691-3696. Epub 2017 Dec 22.
20. Tieniber AD, Shah MM, Eng OS, Nosher JL, Carpizo DR. Preoperative Trans-Arterial Embolization and Surgical Resection for Giant Liver Hemangioma: A Multidisciplinary Approach. Journal of Gastroenterology, Pancreatology & Liver Disorders. 2017 Dec;5(2):1-6.
21. Eng OS, Nelson R, Konstantinidis I, Chao J, Erhunmwunsee L, Raz DJ, Kim JY. Disparities in survival after trimodality therapy for esophageal adenocarcinoma. Diseases of the Esophagus. 2018 Sep 1;31(9). Epub 2018 Mar 8.
22. Eng OS, Turaga KK. Cytoreductive Surgery and HIPEC for Metastatic Colorectal Cancer. Journal
of Surgical Oncology. 2019 Apr;119(5):613-615. Epub 2019 Mar 10. (Invited Review)
23. Eng OS, Ruel N, Raz DJ, Erhunmwunsee L, Melstrom LG, Chao J, Woo Y, Kim J, Kim JY, Sun V. Quality of life and self-management strategies after gastroesophageal cancer surgery. Journal of Pain and Symptom Management. 2018 Aug;56(2):e4-e8. Epub 2018 May 9. S0885-3924(18)30234-3.
24. Eng OS, Raoof M, Blakely AM, Yu X, Lee SJ, Han ES, Wakabayashi MT, Yuh B, Lee B, Dellinger TH. A collaborative surgical approach in upper and lower abdominal cytoreductive surgery in ovarian cancer. Journal of Surgical Oncology. 2018 Jul;119(1):121-126. Epub 2018 Jun 7.
25. Eng OS, Raoof M, O’Leary MP, Lew MW, Wakabayashi MT, Paz IB, Melstrom LG, Lee B. Hypothermia is associated with surgical site infection in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Surgical Infections. 2018 Aug/Sep;19(6):618-621. Epub 2018 Jul 25.
26. LaRocca CJ, Wong P, Eng OS, Raoof M, Warner SG, Melstrom LG. Academic productivity in surgical oncology: Where is the bar set for those training the next generation? Journal of Surgical Oncology. 2018 Sep;118(3):397-402. Epub 2018 Aug 19.
27. Eng OS. Fluids in Abdominal Surgery: What is the Goal? Hepatobiliary Surgery and Nutrition.
2018;7(3):227-228. (Invited Viewpoint)
28. Lafaro KJ, Eng OS, Raoof M, Ituarte P, Warner SG, Singh G, Fong Y, Melstrom LG. A prognostic nomogram for patients with fibrolamellar hepatocellular carcinoma after resection. Hepatobiliary Surgery and Nutrition. 2019 Aug;8(4):338-344. Epub 2019 May 28.
29. Melstrom LG, Eng OS, Raoof M, Singh G, Fong Y, Latorre K, Choi GH, Salem R, Bentrem
DJ, Lewandowski R, Makris E, Poultsides G, Dhar VK, Chadalavada S, Shah SA, Johnson AC, Sekhar A, Kies D, Maithel SK, Alseidi A, Rocha F, Hagendoorn J, Borel Rinkes IHM, Fisher A, Ronnekleiv-Kelly S, Weber SM, Winslow ER, Abbott DE. Is Hepatectomy Safe Following Yttrium-90 Therapy? A Multi-Institutional International Experience. HPB (Oxford). 2019 Nov;21(11):1520-1526. Epub 2019 Apr 17.
30. Levinsky NC, Morris MC, Wilma K, Sussman JJ, Ahmad SA, Cloyd JM, Kimbrough C,
Fournier K, Lee A, Dineen S, Dessureault S, Veerapong J, Baumgartner JM, Clarke C, Zaidi MY, Staley CA, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Ronnekleiv-Kelly S, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Patel SH. Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative. Journal of Gastrointestinal Surgery. 2020 Jan;24(1):155-164. Epub 2019 Aug 19.
31. Poli EC, Millis AM, Berger Y, Sherman SK, Schuitevoerder D, Dahdaleh F, Kamm A, Eng
OS, Turaga KK. Implementation of bundled care to reduce surgical site infections after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Journal of Surgical Oncology. 2019 Nov;120(6):1044-1045. Epub 2019 Aug 19.
32. Wang J, Eng OS, Micic D. Getting to the Root of the Problem. Gastroenterology. 2020
Apr;158(5):1229-1231. Epub 2019 Sep 24.
33. Blakely AM, Chanson D, Wong FL, Eng OS, Sentovich SM, Melstrom KM, Lai LL, Fong Y,
Sun V. Health-Related Quality of Life and Oncologic Outcomes after Surgery in Older Adults with Colorectal Cancer. Supportive Care in Cancer. 2020 Jun;28(6):2857-2865. Epub 2019 Nov 15.
34. Xue L, Hyman NH, Turaga KK, Eng OS. Peritoneal Metastases in Colorectal Cancer: Biology and
Barriers. Journal of Gastrointestinal Surgery. 2020 Mar;24(3):720-727. Epub 2019
Nov 19. (Invited Review)
35. Tun S, Eng OS, Malec M. Editorial about “Health-Related Quality of Life after Cytoreductive
Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin.” Annals of Surgical Oncology. 2020 Mar;27(3):630-631. Epub 2019 Dec 17. (Invited Editorial)
36. Blakely AM, Lafaro KJ, Eng OS, Ituarte PH, Fakih M, Lee B, Raoof M. The Association of
Tumor Laterality and Survival after Cytoreduction for Colorectal Carcinomatosis. Journal of Surgical Research. 2020 Apr;248:20-27. Epub 2019 Dec 13.
37. The Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface
Malignancies: Management of Appendiceal Neoplasms. Annals of Surgical Oncology. Epub 2020 Apr 13.
38. The Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface
Malignancies: Management of Appendiceal Neoplasms. Cancer. Epub 2020 Apr
13.
39. The Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface
Malignancies: Management of Colorectal Metastases. Annals of Surgical Oncology. Epub 2020 Apr 13.
40. The Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface
Malignancies: Management of Colorectal Metastases. Cancer. Epub 2020 Apr
13.
41. The Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface
Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumor. Annals of Surgical Oncology. Epub 2020 Apr 13.
42. The Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface
Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumor. Cancer. Epub 2020 Apr 13.
43. The Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface
Malignancies: Management of Gastric Metastases. Annals of Surgical Oncology. Epub 2020 Apr 13.
44. The Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface
Malignancies: Management of Gastric Metastases. Cancer. Epub 2020 Apr 13.
45. The Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface
Malignancies: Management of Neuroendocrine Tumors. Annals of Surgical Oncology. Epub 2020 Apr 13.
46. The Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface
Malignancies: Management of Neuroendocrine Tumors. Cancer. Epub 2020 Apr
13.
47. The Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface
Malignancies: Management of Ovarian Neoplasms. Annals of Surgical Oncology. Epub 2020 Apr 13.
48. The Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface
Malignancies: Management of Ovarian Neoplasms. Cancer. Epub 2020 Apr 13.
49. The Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface
Malignancies: Palliative Care Considerations. Annals of Surgical Oncology. Epub 2020 Apr 13.
50. The Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface
Malignancies: Palliative Care Considerations. Cancer. Epub 2020 Apr 13.
51. The Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface
Malignancies: Management of Peritoneal Mesothelioma. Annals of Surgical Oncology. Epub 2020 Apr 13.
52. The Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface
Malignancies: Management of Peritoneal Mesothelioma. Cancer. Epub 2020 Apr
13.
53. The Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface
Malignancies: Standards. Annals of Surgical Oncology. Epub 2020 Apr 13.
54. The Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface
Malignancies: Standards. Cancer. Epub 2020 Apr 13.
55. Vining CC, Eng OS, Hogg ME, Schuitevoerder D, Silverman RS, Yao KA, Winchester DJ,
Roggin KK, Talamonti MS, Posner MC, Turaga KK, Tseng J. Virtual Surgical Fellowship Recruitment During COVID-19 and Its Implications for Resident/Fellow Recruitment in the Future. Annals of Surgical Oncology. Epub 2020 May 18.
56. Eng OS, Pawlik TM, Ejaz A. Cancer Surgery During COVID-19: How We Move Forward.
Annals of Surgery. Epub 2020 May 20.
57. Eng OS, Tseng J, Ejaz A, Pawlik TM, Angelos P. Apples to Oranges: Ethical Considerations
in COVID-19 Recovery. Annals of Surgery. Epub 2020 May 20.
58. Vining CC, Izquierdo F, Eng OS, Turaga KK. Cytoreductive Surgery and Hyperthermic
Intraperitoneal Chemotherapy: Technical Considerations and the Learning Curve. Journal of Surgical Oncology. 2020 Jul;122(1):85-95. Epub 2020 May 20. (Invited Review)
59. Schuitevoerder D, Sherman S, Izquierdo F, Eng OS, Turaga KK. Assessment of the surgical workforce pertaining to cytoreductive surgery and heated intraperitoneal chemotherapy in the United States. Annals of Surgical Oncology. Epub 2020 Jul 6.
60. Eng OS, Blakely AM, Lafaro KJ, Fournier KF, Fackche NT, Johnston F, Dineen S, Powers
B, Hendrix R, Lambert LA, Ronnekleiv-Kelly S, Vande Walle K, Grotz TE, Leiting JL, Patel SH, Dhar VK, Baumgartner JM, Lowy AM, Clarke CN, Mogal H, Zaidi MY, Staley CA, Kimbrough C, Cloyd JM, Lee B, Raoof M. Institutional Variation in Recovery After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Opportunity for Enhanced Recovery Pathways. Journal of Surgical Oncology. Epub 2020 Jul 5.
61. Morgan R, Parsad S, Turaga KK, Eng OS. HIPEC with Cisplatin in a Patient with a Prior
Hypersensitivity Reaction to Systemic Oxaliplatin. Basic & Clinical Pharmacology & Toxicology. Epub 2020 Jul 5.
62. Gamboa AC, Lee RM, Turgeon MK, Zaidi MY, Kimbrough CW, Grotz TE, Leiting J, Fournier
K, Lee AJ, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Mogal H, Patel SH, Lee TC, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Cloyd JM, Maithel SK, Staley CA. Implications of Postoperative Complications on Survival after Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative. Annals of Surgical Oncology. Epub 2020 Jul 21.
63. Liu JB, Schuitevoerder D, Vining CC, Berger Y, Turaga KK, Eng OS. Benchmarking
Perioperative Outcomes of Cytoreductive Surgery for Cancer: Implications for Quality Measurement. Annals of Surgical Oncology. Epub 2020 Jul 29.
64. Berger Y, Schuitevoerder D, Vining C, Alpert L, Fenton L, Hindi E, Liao L, Shergill A,
Catenacci D, Polite B, Eng O, Turaga K. Novel Application of Iterative Hyperthermic Intraperitoneal Chemotherapy for Unresectable Peritoneal Metastases from High-grade Appendiceal Ex-goblet Adenocarcinoma. Annals of Surgical Oncology. Epub 2020 Sep 5.
65. Leiting JL, Day CN, Harmsen WS, Cloyd JM, Abdel-Misih S, Fournier K, Lee AJ, Dineen S,
Dessureault S, Veerapongh J, Baumgartner JM, Clarke C, Mogal H, Russell MC, Zaidi MY, Patel SH, Morris MC, Hendrix RJ, Lambert LA, Abbott DE, Pokrzywa C, Raoof M, Eng O, Johnston FM, Greer J, Grotz TE. The impact of HIPEC vs. EPIC for the treatment of mucinous appendiceal carcinoma: a study from the US HIPEC collaborative. International Journal of Hyperthermia. 2020;37(1):1182-1188.
66. Reizine N, Peterson B, Moya S, Wang Y, Tan C, Eng OS, Bilimoria M, Lengyel E, Turaga K,
Catenacci DV. Complete response in chemorefractory EGFR amplified and PD-L1 positive metastatic gastric cancer patient with dual anti-EGFR and anti-PD-1 monoclonal antibody therapy. JCO Precision Oncology. 2020 Oct 2;4:PO20.00239.
67. White MG, Schulte J, Xue L, Berger Y, Schuitevoerder D, Vining C, Kindler H, Husain AN,
Turaga K, Eng OS. Heterogeneity in PD-L1 Expression in Malignant Peritoneal Mesothelioma with Systemic or Intraperitoneal Chemotherapy. British Journal of Cancer. Epub 2020 Oct 26.
68. Eng OS, Pawlik TM, Ejaz A. Response to: Comment on Cancer Surgery During COVID-19:
How We Move Forward. Annals of Surgery. Epub 2020 Nov 17. (Invited
Response)
69. Wiseman JT, Abdel-Misih S, Beal EW, Zaidi MY, Staley CA, Grotz T, Leiting J, Fournier K, Lee AJ,
Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, Eng O, Fackche N, Greer J, Pawlik TM, Cloyd JM. A multi-institutional analysis of Textbook Outcomes among patients undergoing cytoreductive surgery for peritoneal surface malignancies. Surgical Oncology. Epub 2021 Nov 20.
70. Catenacci D, Moya S, Lomnicki S, Chase L, Peterson B, Reizine N, Alpert L, Setia N, Xiao
S, Hart J, Siddiqui U, Hogarth K, Eng OS, Turaga K, Roggin K, Posner M, Chang P, Narula S, Rampurwala M, Ji Y, Karrison T, Liao C, Polite B, Kindler H. Personalized antibodies for gastroesophageal adenocarcinoma (PANGEA): a phase 2 study evaluating an individualized treatment strategy for metastatic disease. Cancer Discovery. Epub 2020 Nov 24:CD-20-1408.
71. White MG, Eng OS. Response to Comment on Heterogeneity in PD-L1 expression in
malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy. British Journal of Cancer. Epub 2020 Dec 14. (Invited Response)
72. Morgan RM, Tun S, Eng OS. Quality of life after cytoreductive surgery and hyperthermic
intraperitoneal chemotherapy: a narrative review. Digestive Medicine Research. 2020 Dec 30;3:54. (Invited Review)
73. Morgan R, Tun S, Eng OS. Fast facts and concepts #412. Hyperthermic intraperitoneal
chemotherapy (HIPEC): an overview. Journal of Palliative Medicine. 2021 Apr;24(4):621-622.
74. Berger Y, Giurcanu M, Vining CC, Schuitevoerder D, Posner MC, Roggin KK, Polite BN,
Liao CY, Eng OS, Catenacci DVT, Turaga KK. Cytoreductive surgery in selected patients with metastatic gastric cancer treated with systemic chemotherapy. Annals of Surgical Oncology. Epub 2021 Jan 8.
75. Blakely AM, Eng OS, Nelson RA, Erhunmwunsee L, Raz DJ, Paz IB, Kim JY. Results of
Comprehensive Dysphagia Evaluation and Delayed Oral Intake Following Esophagectomy. Annals of Esophagus. 2021.
76. Dhiman A, Fenton E, Whitridge J, Belanski J, Petersen W, Macaraeg S, Rangrass G, Shergill A,
Eng O, Turaga K. Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: Enhanced Recovery and HIPEC. Annals of Surgical Oncology. Epub 2021 May 5. (Invited Manuscript)
77. Goldberg EM, Berger Y, Sood D, Kurnit KC, Kim JS, Lee NK, Yamada SD, Turaga KK, Eng OS.
Differences in Sociodemographic Disparities in Patients Undergoing Surgery for Advanced Colorectal and Ovarian Cancer. Annals of Surgical Oncology. Epub 2021 May 6.
78. Goldberg EM, Eng OS. ASO Author Reflections: Disparities in Access to Cytoreductive Surgery.
Accepted to Annals of Surgical Oncology. Epub 2021 May 19. (Invited Manuscript)
79. White MG, Morgan RM, Drazer M, Eng OS. Gastrointestinal Surgical Emergencies in the
Neutropenic Immunocompromised Patient. Journal of Gastrointestinal Surgery. Epub 2021 Sep 10. (Invited Review)
80. Brajcich BC, Benson AB, Gantt G, Eng OS, Marsh R, Mulcahy M, O’Brien B, Polite BN, Shogan
BD, Yang AD, Merkow RP. Management of Colorectal Cancer During the COVID-19 Pandemic: Recommendations from a Statewide Multidisciplinary Cancer Collaborative. Journal of Surgical Oncology. Epub 2021 Nov 25.
81. Vierra M, Dhiman A, Witmer H, Ulrich L, Hindi E, Fenton E, Shergill A, Eng OS, Polite B, Turaga K.
Celecoxib and Myrtol: A Novel Therapy for Appendiceal Mucinous Neoplasms with Peritoneal Dissemination. American Journal of Clinical Oncology. Epub 2021 Nov 30.
82. Schwarz JL, Kurnit KC, Eng OS. Parasitic Leiomyomas Requiring Cytoreductive Surgery with
Uterine Preservation: A Case Report. The Journal of Reproductive Medicine. Vol 66 2021 Dec.
83. Dhiman A, Vining C, Witmer H, Sood D, Shergill A, Kindler H, Roggin K, Posner M, Ahmed O,
Liauw S, Pitroda S, Liao A, Karrison T, Weischselbaum R, Polite B, Eng O, Catenacci D, Turaga K. Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy with and without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinioma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels. Annals of Surgical Oncology. Epub 2022 Jan 5.
84. Hsu PJ, Singh K, Dhiman A, Witmer HDD, He C, Eng OS, Catenacci DVT, Posner MC, Turaga KK.
Utility of perioperative measurement of cell free DNA and circulating tumor DNA in informing the prognosis of gastrointestinal cancers: a systematic review. JCO Precision Oncology. 2022 Feb;6:e2100337.
85. Vierra M, Morgan RM, Eng OS. Advances in Therapeutics for Peritoneal Metastases from
Colorectal Cancer. Digestive Medicine Research. 2022;5:18. (Invited Review)
86. Sood D, Dhiman A, Ong CT, Liu AY, Belanski J, Turaga KK, Eng OS. The Impact of COVID-19-Related Delays in Surgical Management of Peritoneal Surface Malignancies. Annals of Surgical Oncology. Epub 2022 May 3.
87. Morgan RM, Yan A, Dhiman A, Shergill A, Polite B, Turaga KK, Eng OS. Survival in Total Pre-Operative vs. Peri-Operative Chemotherapy for Patients with Metastatic High-Grade Appendiceal Adenocarcinoma Undergoing CRS/HIPEC. Journal of Gastrointestinal Surgery. Epub 25 July 2022.
Grants
Appendix Cancer Pseudomyxoma Peritonei (ACPMP) Research Foundation Grant 12/2020-12/2022, “Assessment of the Effects of HIPEC on the Genetic Landscape of Peritoneal Metastases from High Grade Appendiceal Cancers”
University of Chicago Comprehensive Cancer Center Junior Faculty Award 08/2021-01/2022, “Investigation of the Role of an Olfactory Receptor, OR10J5, in Colorectal Cancer Metastasis”
Professional Societies
American College of Surgeons
Association for Academic Surgery
Society of Surgical Oncology
American Society of Clinical Oncology
Society of Asian Academic Surgeons
American Society for Peritoneal Surface Malignancies
Society for Surgery of the Alimentary Tract
Last updated
08/16/2022